Locations:

Tag: light-chain amyloidosis

Advanced Noninvasive Tools for the Diagnosis of Cardiac Amyloidosis: What’s Their Role?

January 14, 2021/Cancer/Benign Hematology

Combination Therapy Triggers Complete Hematological Response in Amyloidosis Patient

Finally, promising new therapies for this difficult disease

December 18, 2020/Cancer/News & Insight

Combination Therapy for AL Amyloidosis Safe, Tolerable and Promising in Early Results

Cael-101 + CyBorD dosing and outcomes

February 26, 2019/Cancer/Research

Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis

Daratumumab is effective and safe

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy